Your browser doesn't support javascript.
loading
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Senkowski, Wojciech; Gall-Mas, Laura; Falco, Matías Marín; Li, Yilin; Lavikka, Kari; Kriegbaum, Mette C; Oikkonen, Jaana; Bulanova, Daria; Pietras, Elin J; Voßgröne, Karolin; Chen, Yan-Jun; Erkan, Erdogan Pekcan; Dai, Jun; Lundgren, Anastasia; Grønning Høg, Mia Kristine; Larsen, Ida Marie; Lamminen, Tarja; Kaipio, Katja; Huvila, Jutta; Virtanen, Anni; Engelholm, Lars; Christiansen, Pernille; Santoni-Rugiu, Eric; Huhtinen, Kaisa; Carpén, Olli; Hynninen, Johanna; Hautaniemi, Sampsa; Vähärautio, Anna; Wennerberg, Krister.
Afiliación
  • Senkowski W; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: wojciech.senkowski@bric.ku.dk.
  • Gall-Mas L; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark.
  • Falco MM; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Li Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Lavikka K; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Kriegbaum MC; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark.
  • Oikkonen J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Bulanova D; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark.
  • Pietras EJ; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Voßgröne K; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Chen YJ; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Erkan EP; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Dai J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Lundgren A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Grønning Høg MK; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark.
  • Larsen IM; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark.
  • Lamminen T; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Kaipio K; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Huvila J; Department of Pathology, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, 00260 Helsinki, Finland.
  • Engelholm L; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark.
  • Christiansen P; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Santoni-Rugiu E; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Huhtinen K; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Carpén O; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, 00260 Helsinki, Finland.
  • Hynninen J; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Hautaniemi S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Vähärautio A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Wennerberg K; Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: krister.wennerberg@bric.ku.dk.
Dev Cell ; 58(12): 1106-1121.e7, 2023 06 19.
Article en En | MEDLINE | ID: mdl-37148882
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Revista: Dev Cell Asunto de la revista: EMBRIOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Revista: Dev Cell Asunto de la revista: EMBRIOLOGIA Año: 2023 Tipo del documento: Article